Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05652023 · ClinicalTrials.gov registry record
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
A clinical trial of Overactive Bladder and Bladder Dysfunction, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 2,023
- Enrollment target
- 1
- Study location
NCT05652023 is a study of Overactive Bladder and Bladder Dysfunction that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 2,023 participants, above the 167-participant average among 45 other Overactive Bladder trials with a reported enrollment target (1111% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05652023, a study of Overactive Bladder and Bladder Dysfunction, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 2,023 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,023 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2028-12-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05652023
The ClinicalTrials.gov registry entry for NCT05652023 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,023 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 167-participant average among 45 other Overactive Bladder trials with a reported enrollment target (1111% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 0 interventions.
NCT05652023 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05652023 about?
NCT05652023 is a clinical study titled "Noninvasive Ultrasound Assessment of Detrusor Dysfunction". The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
What is the current status of trial NCT05652023?
This trial is currently recruiting. The enrollment target is 2,023 participants. The study started on 2023-04-20. Estimated completion is 2028-12-20.
What conditions does trial NCT05652023 study?
This clinical trial studies the following conditions: Overactive Bladder, Bladder Dysfunction, BPH With Urinary Obstruction.
Who is sponsoring clinical trial NCT05652023?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05652023 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.